iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$4.30M
Expense Ratio	0.47%
PE Ratio	n/a
Shares Out	n/a
Dividend (ttm)	$0.01
Dividend Yield	0.04%
Ex-Dividend Date	Jun 7, 2023
Payout Ratio	n/a
1-Year Return	-11.32%

Volume	449
Open	22.99
Previous Close	22.82
Day's Range	22.99 - 22.99
52-Week Low	19.08
52-Week High	27.43
Beta	n/a
Holdings	56
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Net Index

Top 10 Holdings

43.98% of assets

Name	Symbol	Weight
Cerevel Therapeutics Holdings, Inc.	CERE	6.24%
Biohaven Pharmaceutical Holding Company Ltd.	BHVN	5.00%
Karuna Therapeutics, Inc.	KRTX	4.43%
Intra-Cellular Therapies, Inc.	ITCI	4.40%
SK BIOPHARMACEUTICALS LTD	326030.KS	4.39%
Neurocrine Biosciences, Inc.	NBIX	4.30%
Axonics, Inc.	AXNX	3.93%
Xenon Pharmaceuticals Inc.	XENE	3.87%
Integra LifeSciences Holdings Corporation	IART	3.83%
Catalyst Pharmaceuticals, Inc.	CPRX	3.61%

Dividends

Ex-Dividend	Amount	Pay Date
Jun 7, 2023	$0.00824	Jun 13, 2023